Patent · US Active

Apomorphine-palmitic acid cocrystal solid particle crystalline form

US11382867B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

LEUKOS BIOTECH, S.L. · ES

Inventors

Enrique Llaudet Carles · Barcelona, ES
Nicolas Tesson · Barcelona, ES
Montserrat Trilla Castaño · Barcelona, ES

Key dates

Filing date	Jan 15, 2019
Grant date	Jul 12, 2022
Priority date	—
Expiry date	May 1, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D221/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical composition comprising apomorphine (APO) in a solid crystalline form, wherein the solid crystalline form is an APO·palmitic acid cocrystal solid particle crystalline form.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.